Comparison between Molbio Diagnostics IPO and OnEMI Technology IPO.
Molbio Diagnostics IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while OnEMI Technology IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Molbio Diagnostics IPO is up to ₹0.00 Cr whereas the issue size of the OnEMI Technology IPO is up to ₹925.92 Cr. The final issue price of Molbio Diagnostics IPO is and of OnEMI Technology IPO is ₹171.00 per share.
| Molbio Diagnostics IPO | OnEMI Technology IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹1 per share |
| Issue Price (Lower) | ₹162.00 per share | |
| Issue Price (Upper) | ₹171.00 per share | |
| Issue Price (Final) | ₹171.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 87 shares | |
| Fresh Issue Size | 0 shares | 4,97,07,602 shares |
| Fresh Issue Size (Amount) | up to ₹200.00 Cr | up to ₹850.00 Cr |
| OFS Issue Size | 1,25,56,000 shares | 44,39,788 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹75.92 Cr |
| Issue Size Total | 0 shares | 5,41,47,390 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹925.92 Cr |
Molbio Diagnostics IPO opens on , while OnEMI Technology IPO opens on Apr 30, 2026. The closing date of Molbio Diagnostics IPO and OnEMI Technology IPO is , and May 05, 2026, respectively.
| Molbio Diagnostics IPO | OnEMI Technology IPO | |
|---|---|---|
| Anchor Bid Date | Apr 29, 2026 | |
| Issue Open | Apr 30, 2026 | |
| Issue Close | May 05, 2026 | |
| Basis Of Allotment (Tentative) | May 06, 2026 | |
| Initiation of Refunds (Tentative) | May 07, 2026 | |
| Credit of Share (Tentative) | May 07, 2026 | |
| Listing date (Tentative) | May 08, 2026 | |
| Anchor Lockin End date 1 | Jun 04, 2026 | |
| Anchor Lockin End date 2 | Aug 03, 2026 |
Molbio Diagnostics IPO P/E ratio is , as compared to OnEMI Technology IPO P/E ratio of 12.65.
| Molbio Diagnostics IPO | OnEMI Technology IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 46.65 | 32.30 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 23.33 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.65 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹2881.06 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 16.20 | 17.74 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 20.98 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.50 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹12.29 | ₹13.52 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 15.23 | 15.97 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Molbio Diagnostics IPO Retail Individual Investors (RII) are offered 0 shares while in OnEMI Technology IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Molbio Diagnostics IPO and 1,08,29,478 shares in OnEMI Technology IPO.
| Molbio Diagnostics IPO | OnEMI Technology IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 1,62,44,216 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 1,08,29,478 shares |
| NII | 0 shares | 81,22,109 shares |
| RII | 0 shares | 1,89,51,587 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 5,41,47,390 shares |
Molbio Diagnostics IPO subscribed in total, whereas OnEMI Technology IPO subscribed 6.97x.
| Molbio Diagnostics IPO | OnEMI Technology IPO | |
|---|---|---|
| QIB (times) | 25.97x | |
| NII (times) | 6.91x | |
| Big NII (times) | 8.59x | |
| Small NII (times) | 3.53x | |
| RII (times) | 2.13x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 6.97x |
